Photodynamic therapy for cosmetic uses on the skin: An update 2010

Giornale Italiano di Dermatologia e Venereologia

Volumn 145, Issue 4, 2010, Pages 525-541

  Gold, M H ^a,b,c,d  

^a GOLD SKIN CARE CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUDAN UNIVERSITY   (China)

^d No 1 Hospital of China Medical University   (China)

Author keywords

Aminolevulinic acid; Lasers; Photochemotherapy; Photosensitizing agents

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ANTIBIOTIC AGENT; ISOTRETINOIN; PHOTOSENSITIZING AGENT; PLACEBO; SUNSCREEN;

ACNE VULGARIS; ACTINIC KERATOSIS; ALOPECIA AREATA; ANTIBIOTIC THERAPY; BASAL CELL CARCINOMA; BLUE LIGHT; BOWEN DISEASE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CRYOTHERAPY; CUTANEOUS T CELL LYMPHOMA; DERMATOLOGY; DRUG EFFICACY; HIRSUTISM; HUMAN; KAPOSI SARCOMA; KERATOACANTHOMA; MELANOMA; MOLLUSCUM CONTAGIOSUM; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PSORIASIS VULGARIS; PULSED DYE LASER; REJUVENATION; REVIEW; SKIN; SKIN CANCER; SKIN CARE; SKIN DEFECT; SUPPURATIVE HIDRADENITIS; UNITED STATES;

EID: 78649284211     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Raab O. Ueber die wirkung fluoreszierenden stoffe auf infusorien. Z Biol 1900;39:524-6.
2. Von Tappeiner H, Jodblauer A. Uber die wirkung der photodynamischen (fluorescierenden) staffe auf protozoan und enzyme. Dtsch Arch Klin Med 1904;80:427-87.
3. Jesionek A, Von Tappeiner H. Behandlung der hautcarcinome nut fluorescierenden stoffen. Dtsch Arch Klin Med 1905;85:223-7.
4. Hausman W. Die sensibilisierende wirkung des hamatoporphyrins. Biochem Zeit 1911:276-316.
5. Meyer-Betz F. Untersuchungen uber die bioloische (photodynamische) wirkung des hamatoporphyrins und anderer derivative des blut- und gallenfarbstoffs. Dtsch Arch Klin Med 1913; 112:476-503.
6. Auler H, Banzer G. Untersuchungen ueber die rolle der porphyrine bei geschwulstkranken menschen und tieren. Z Krebsforsch 1942;53:65-8.
7. Figge FHJ, Weiland GS, Manganiello LDJ. Cancer detection and therapy. Affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 1948;68:640.
8. Dougherty TJ, Kaufman JE, Goldfarb A, Weishaupt KR, Boyle D, Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38:2628-35.
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experiences. J Photochem Photobiol 1990;B 6:143-8.
10. Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg 2004;30:1077-84.
11. Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001;45:96-104.
12. Jeffes EW Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J Dermatolog Treat 2002;13 Suppl 1:S19-23.
13. Nestor MS, Goldberg DJ, Goldman MP, Weiss RA, Rigel DS. Photorejuvenation: non-ablative skin rejuvenation using intense pulsed light. Skin & Aging 2003;3,8
14. Goldman M, Eckhouse S. Photothermal sclerosis of leg veins. Dermatol Surg 1996;22:323-30.
15. Anderson RR, Parish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-7.
16. Biter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg 2000;26:835-42.
17. Goldberg DJ, Cutler KB. Non-ablative Treatment of Rhytids with Intense Pulsed Light. Lasers Surg Med 2000;26:196-200.
18. Weiss RA, Weiss MA, Beasley KL. Rejuvenation of photoaged skin: 5 years results with intense pulsed light of the face, neck and chest. Dermatol Surg 2002;28:115-9.
19. Negishi K, Tezuka Y, Kushikata N, Wakamatsu S. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001;27:627-31.
20. Hernandez-Perez E. Gross and microscopic findings in patients submitted to nonablative full-face resurfacing using intense pulsed light: a preliminary study. Dermatol Surg 2002;28:651-5.
21. Nestor MS, Gold MH, Kauvar AN. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006;5:140-54.
22. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003;139:1313-20.
23. Gold MH. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis 2002;69(6 Suppl):8-13.
24. Tourna D, Yaar M, Whitehead S, Konnikov N, Gilchrest BA. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004;140:33-40.
25. Ruiz-Rodriguez R, Sanz-Sanchez T, Cordoba S. Photodynamic photorejuvenation. Dermatol Surg 2002;28:742-4.
26. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA, Lewis TL. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 2004;3(6 Suppl):S6-9.
27. Goldman MP, Atkin D, Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Surg Med 2002;14:24.
28. Avram DK, Goldman MP. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 2004;3(1 Suppl): S36-9.
29. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic chelitis. J Drugs Dermatol 2004;3:548-51.
30. Alster Ts, Tanzi EL, Welch EC. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 2005;4:35-8.
31. Key DJ. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmetic Derm 2005;18:31-6.
32. Marmur ES, Phelps R, Goldberg DJ. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 2005;7:21-4.
33. Dover JS, Bhatia AC, Stewart B, et al.. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 2005;141:1247-52.
34. Gold MH, Bradshaw VL, Boring MM, Bridges TM, Biron JA. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 2006;32:795-801.
35. Redbord KP, Hanke CW. Topical photodynamic therapy for dermatologic disorders: results and complications. J Drugs Dermatol 2007;6:1197-202.
36. Tschen EH, Wong DS, Pariser DM, Dunlap FE, Houlihan A, Ferdon MB et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 2006;155:1262-9.
37. Data on file. Galderma.
38. Szeimies RM, Karrer S, Radakovic-Fijan S, Tanew A, Calzavara-Pinton PG, Zane C et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 2002;47:258-62.
39. Bjerring P, Funk J, Poed-Petersen J, Soderberg U. Randomized double blind study comparing photodynamic therapy (PDT) with Metvix® to PDT with placebo cream in actinic keratosis. Abstract accepted at the 29th Nordic Congress of Dermatology and Venereology, Gothenborg; 2001.
40. Freeman M, Vinciullo C, Francis D, Spelman L, Nguyen R, Fergin P et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003;14:99-106.
41. Pariser DM, Lowe NJ, Stewart DM, Jarratt MT, Lucky AW, Pariser RJ et al. Photodynamic therapy with topical methyl aminolevulinate (Metvix®) is effective and safe in the treatment of actinic keratosis: results of a prospective randomized trial. J Am Acad Dermatol 2003;48:227-32.
42. Tarstedt M, Rosdahl I, Berne B, Svanberg K, Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 2005;85:424-8.
43. Morton C, Campbell S, Gupta G, Keohane S, Lear J, Zaki I et al. Intraindividual, right-left comparison of topical methyl aminolaevulinate- photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Br J Dermatol 2006;155:1029-36.
44. Pariser D, Loss R, Jarratt M, Abramovits W, Spencer J, Geronemus R et al. Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study. J Am Acad Dermatol 2008;59:569-76.
45. Szeimies RM, Matheson RT, Davis SA, Bhatia AC, Frambach Y, Klövekorn W, Fesq H et al. Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study. Dermatol Surg 2009;35:586-92.
46. Zane C, Capezzera R, Sala R, Venturini M, Calzavara-Pinton P. Clinical and echographic analysis of photodynamic therapy using methylaminolevulinate as sensitizer in the treatment of photodamaged facial skin. Lasers Surg Med 2007; 39:203-9.
47. Leyden JJ. Therapy for Acne vulgaris. N Engl J Med 1997;336:1156-62.
48. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ et al. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003;49:S1-S37.
49. Velicer CM., eckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004;291:827-35.
50. Hongcharu W, Taylor CR, Chang Y, Aghassi D, Suthamjariya K, Anderson RR. Topical ALA-photodynamic therapy for the treatment of Acne vulgaris. J Invest Dermatol 2000;115:183-192.
51. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. t al.. Photodynamic therapy for Acne vulgariswith topical 5-aminolevulinic acid. Arch Dermatol 2000;136:1093-5.
52. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of Acne vulgaris with topical delta aminolevulinic acid and incoherent light in Japanese patients. Brit J Dermatol 2001;144:575-9.
53. Goldman MP, Boyce S. A single-center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe Acne vulgaris. J Drugs Dermatol 2003;2:393-6.
54. Gold, MH. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory Acne vulgaris. J Drugs Dermatol 2004:3:S14-S18.
55. Gold MH, Rao J, Goldman MP, Bridges TM, Bradshaw VL, Boring MM et al. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory Acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution. J Drugs Dermatol 2005;4:64-70.
56. Gold MH. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory Acne vulgaris. J Drugs Dermatol 2004;3:S14-S18.
57. Taub AF. PDT for the treatment of acne: A pilot study. J Drugs Dermatol 2004;3:S10-S14.
58. Alexiades-Armenakas. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne. J Drugs Dermatol 2006;5:45-55.
59. Miller A, Van Camp A. Treatment of cane vulgaris with photodynamic therapy: the use of aminolevulinic acid and green light. Cosm Derm 2006;10:624-7.
60. Santos AV, Belo VG, Santos G. Effectiveness of photodynamic therapy with topical 5-Aminolevulinic acid and intense pulsed light versus intense pulsed light along in the treatment of Acne vulgaris: comparative study. Dermatol Surg 2005;31(8 Pt 1):910-5.
61. Rojanamatin J, Choawawanich P. Treatment of inflammatory facial Acne vulgaris with intense pulsed light and short contact of topical 5-aminolevulinic acid: a pilot study. Dermatol Surg 2006;32:991-6; discussion 996-7.
62. Wiegell SR, Wulf HC. Photodynamic therapy of Acne vulgaris using methyl aminolevulinate: a blinded, randomized, controlled trial. Br J Dermatol 2006;154:969-76.
63. Horfelt C, Funk J, Frohm-Nilsson M. Topical methyl aminolevulinate photodynamic therapy for treatment of facial Acne vulgaris: results of a randomized, controlled study. Br J Dermatol 2006;155:608-13.
64. Horio T, Horio O, Miyauchi-Hashimoto H, Ohnuki M, Isei T. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolaevulinic acid and slide projector. Br J Dermatol 2003;148:1274-6.
65. Alster TS, Tanzi EL. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2003;2:501-4.
66. Richey DF. Aminolevulinic acid photodynamic therapy for sebaceous gland hyperplasia. Dermatol Clin 2007;25:59-65.
67. Gold MH. A single center, open label investigator study of photodynamic therapy in the treatment of sebaceous gland hyperplasia with topical 20% 5-aminolevulinic acid with visible blue light or intense pulsed light. J Am Acad Derm 2004;50:P638.
68. Gold MH, Bridges TM, Bradshaw VL, Boring M. ALA/PDT & blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 2004;3:S32-39.
69. Strauss RM, Pollock B, Stables GI, Goulden V, Cunliffe WJ. Photodynamic therapy using aminolevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 2005;152:803-4.
70. Rivard J, Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol 2006;5:556-61.
71. Nestor M, Gold MH, Kauvar A, Taub AF, Geronemus RG, Ritvo EC et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 2006;5:140-54.
72. Gold, MH, Nestor MS. Current treatments of actinic keratosis. J Drugs Dermatol 2006:17-25.
73. Gold MH, Biron JA, Boring M, Bridges TM, Bradshaw VL. Treatment of moderate to severe inflammatory Acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source. J Drugs Dermatol 2007;6:319-22.
74. Fang JY, Lee WR, Shen SC, Fang YP, Hu CH. Enhancement of topical 5-aminolaevulinic acid delivery by Erbium: YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004;151:132-40.
75. Gold, MH, Biron JA. A novel skin cream containing a mixture of human growth factors and cytokines for the treatment of adverse events associated with photodynamic therapy. J Drugs Dermatol 2006;5:796-8.
76. Gold, MH. Single-center, split-face, double-blind, randomized clinical trial of the efficacy of a trolamine-containing topical emulsion and a topical petrolatum-based product in reducing redness and peeling after treatment with a microlaser peel. Poster Presentation American of Academy Dermatology Annual meeting 2006, San Francisco, CA.
77. Gold MH, Ribet V, Gral N. Calming efficacy and tolerance of avene spring water gel after epilatory laser treatment combined to healing cream in adults. Poster Presentation American of Academy Dermatology Annual meeting 2006, San Francisco, CA.